Enoxaparin

Prevention of Blood Clots

Enoxaparin is frequently prescribed to prevent a condition called deep vein thrombosis (DVT), which occurs when blood clots form in the legs. This prevention is particularly important for:

• People undergoing certain types of surgery, such as hip replacement, knee replacement, or abdominal surgery.
• Patients who have severely restricted mobility during an acute illness.

Preventing DVT is critical because these clots can travel to the lungs, causing a life-threatening condition known as a pulmonary embolism.

Treatment of Existing Clots

This medication is also used to treat active blood clots in the legs or lungs. In these cases, it may be used alone or in combination with other oral blood thinners like warfarin.

Heart Health and Complications

Enoxaparin is used to manage and prevent complications from specific heart-related issues, including:

• Unstable angina (a type of severe chest pain).
• Certain types of heart attacks, such as ST-elevation myocardial infarction (STEMI).

In these situations, it is often used alongside aspirin to help keep blood flowing smoothly and prevent further cardiac events.

Mechanism of Action

Enoxaparin is an anticoagulant, or blood thinner, that belongs to a group of medications called low molecular weight heparins. It works by interfering with the body's natural blood-clotting process to help blood flow more easily through the veins and arteries.

The medication functions by binding to a protein in the blood called antithrombin III. This binding action enhances the protein's ability to block specific clotting factors, primarily Factor Xa and thrombin. These factors are necessary for blood to thicken and form a solid clot.

Effects on the Body

By inhibiting these clotting factors, enoxaparin achieves the following:

• Prevention: It reduces the risk of new blood clots forming in the circulatory system.
• Stabilization: It prevents existing blood clots from becoming larger or breaking off and traveling to other parts of the body, such as the lungs.

While enoxaparin helps prevent and stabilize clots, it does not directly dissolve clots that have already formed. Instead, it stops the clot from growing, which allows the body's natural mechanisms to gradually break the clot down over time.

Common Side Effects

• Pain, bruising, or redness at the injection site
• Nausea
• Diarrhea
• Fever
• Swelling of the hands, ankles, or feet

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Unusual bleeding, such as nosebleeds, bleeding gums, or heavy menstrual periods
• Blood in the urine or stools (which may appear red, dark brown, or black and tarry)
• Coughing up blood or vomit that looks like coffee grounds
• Signs of an allergic reaction, such as skin rash, hives, itching, or swelling of the face and throat
• Difficulty breathing or swallowing
• Sudden weakness, numbness, or tingling, particularly in the legs
• Loss of bladder or bowel control
• Severe headache or dizziness

Spinal/Epidural Hematoma Warning

Enoxaparin carries a boxed warning regarding the risk of spinal or epidural bleeding (hematoma) in patients who receive spinal anesthesia or undergo spinal puncture. These hematomas can cause long-term or permanent paralysis. The risk is higher in those using indwelling epidural catheters, taking other medications that affect blood clotting (such as NSAIDs), or those with a history of spinal surgery or traumatic punctures.

Risk of Bleeding

As an anticoagulant, enoxaparin increases the risk of major and potentially fatal bleeding. It should be used with extreme caution in patients with conditions that increase bleeding risk, such as uncontrolled hypertension, active gastrointestinal ulcers, or recent surgery on the brain, spine, or eyes. Signs of bleeding, such as unusual bruising, blood in the urine or stool, or coffee-ground vomit, require immediate medical evaluation.

Heparin-Induced Thrombocytopenia (HIT)

Enoxaparin can cause a serious immune-mediated reaction known as heparin-induced thrombocytopenia (HIT), which results in a significant drop in platelet counts and may lead to new blood clots. Healthcare providers typically monitor platelet counts regularly during treatment. The medication is contraindicated in patients with a history of HIT.

Contraindications and Precautions

• Allergies: Enoxaparin is derived from porcine (pig) intestinal tissue and should not be used by individuals with a known hypersensitivity to pork products, heparin, or enoxaparin. Multi-dose vials containing benzyl alcohol should be avoided in patients with a known sensitivity to that preservative.
• Kidney Function: Patients with severe kidney impairment may require dosage adjustments because the drug is cleared through the kidneys, increasing the risk of accumulation and bleeding.
• Interchangeability: Enoxaparin is not interchangeable unit-for-unit with heparin or other low molecular weight heparins.
• Active Bleeding: This medication must not be used in patients with active major bleeding.

Pregnancy

Enoxaparin is often used during pregnancy to prevent or treat blood clots. Current evidence suggests that the medication does not cross the placenta and is unlikely to cause harm to the unborn baby. However, it should only be used during pregnancy when clearly needed and under the direct supervision of a healthcare provider.

Pregnant women with mechanical heart valves are at a higher risk for developing blood clots. If enoxaparin is used in these individuals, frequent monitoring is required because there have been reports of blood clots forming on the valves in pregnant patients.

A major concern during delivery is the risk of spinal or epidural hematoma (bleeding near the spinal cord). If enoxaparin is in the system during spinal anesthesia or a spinal tap, it can cause bleeding that leads to long-term or permanent paralysis. Healthcare providers typically coordinate the timing of the medication and delivery to reduce this risk.

Breastfeeding

It is not known for certain if enoxaparin passes into human breast milk. Because many drugs are excreted in breast milk, caution is advised. Patients should discuss the potential risks and benefits with their healthcare provider before breastfeeding while using this medication.

Available Forms

Enoxaparin is a liquid medication administered by injection. It is primarily given as a subcutaneous injection, which is an injection into the fatty tissue just beneath the skin. In specific medical situations, it may be administered as an intravenous injection directly into a vein by a healthcare professional.

The medication is supplied in the following formats:

• Pre-filled syringes: These are single-dose syringes that come ready for use. Some versions include a graduated scale for measurement, and many feature a safety system to protect against needle sticks after the injection is completed.
• Multiple-dose vials: These containers hold a volume of medication intended for multiple uses.

FDA Approval Status

Enoxaparin was first approved by the U.S. Food and Drug Administration (FDA) in 1993. In 2010, the FDA approved the first generic version of enoxaparin sodium injection. Generic versions are required to meet the same standards for safety and effectiveness as the original brand-name medication.

Boxed Warning

Spinal/Epidural Hematoma Risk: Enoxaparin carries a Boxed Warning because patients who receive spinal anesthesia or undergo a spinal puncture while taking this medication are at risk of developing a blood clot in the spine (spinal or epidural hematoma). These hematomas can cause long-term or permanent paralysis. The risk is increased by the use of indwelling epidural catheters, the use of other drugs that affect blood clotting (such as NSAIDs), or a history of spinal surgery or deformity.

Approved Indications

The FDA has approved enoxaparin for several specific medical uses:

• Prevention of deep vein thrombosis (DVT) in patients undergoing abdominal surgery, hip replacement surgery, or knee replacement surgery.
• Prevention of DVT in medical patients who have severely restricted mobility during an acute illness.
• Treatment of acute deep vein thrombosis, with or without pulmonary embolism (a blood clot in the lung).
• Treatment of acute coronary syndromes, including unstable angina and certain types of heart attacks (non-Q-wave myocardial infarction and ST-segment elevation myocardial infarction).

Generic Availability

Enoxaparin is available as a generic drug, which is generally less expensive than the brand-name version, Lovenox. The FDA has approved generic versions of enoxaparin, ensuring they meet the same standards for quality, strength, and purity as the original medication.

Insurance and Out-of-Pocket Costs

The amount you pay for enoxaparin will depend on several factors:

• Insurance Plan: Coverage varies between private insurance, Medicare, and Medicaid. Some plans may require prior authorization before covering the medication.
• Pharmacy Selection: Prices can vary between different pharmacies. Some may offer lower prices through discount programs or mail-order options.
• Formulation: Enoxaparin is available in various strengths and delivery formats, such as prefilled syringes or multiple-dose vials, which can affect the total price.

If you are concerned about the cost, you may want to discuss generic options with your healthcare provider or pharmacist.